Acclinate, a leading digital health company, announced today the appointment of Kevin Walton as Vice President of Product and Technology.
Acclinate, a leading digital health company, announced today the appointment of Kevin Walton as Vice President of Product and Technology. Walton brings 10+ years of pharmaceutical and technology experience to the company. In this role, Walton will oversee product development at Acclinate.
Before joining Acclinate, Kevin served as a Director in PwC’s Cloud & Digital practice where he advised Fortune 500 healthcare and life sciences companies on product strategy using emerging technologies such as cloud and AI/ML. Most recently Kevin developed industry-leading cloud platforms across digital health, clinical trial design, and pharmacovigilance.
"Hiring Kevin as our VP of Product and Technology reflects our continued growth and commitment to providing best-in-class technology solutions to support our customers," said Acclinate Co-founder and CEO Del Smith. "Kevin brings a wealth of experience in product design, data science, and development to the company that is unmatched."
"Del and Tiffany have a vision for Acclinate that I'm excited to be a part of." said Walton, "Acclinate has a unique value proposition - developing a diverse and inclusive ecosystem for clinical trials through culture and technology. I’m looking forward to bringing my insight and experience to such a high-performing team."
Kevin holds a Bachelor's degree in Computer Science from Morehouse College and a Master's Degree in Information Systems Management from Carnegie Mellon University.
Acclinate continues to break down barriers for communities of color in the clinical trial space and create a more robust and efficient process for researchers and sponsors.
Acclinate™ is a Birmingham-based digital health company helping pharmaceutical companies and healthcare organizations access and engage communities of color so that research is more inclusive.